MetaCap

Strata Critical Medical (SRTA) vs Starling Oncology (STLN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Strata Critical Medical (SRTA) has outperformed Starling Oncology (STLN) over the past year, gaining 8.6% versus a loss of 4.2%. Over five years, SRTA leads with a -46.8% price change compared with -55.3% for STLN. Strata Critical Medical is the larger company by market cap ($407.3 million vs $306.0 million), about 1.3 times the size.

Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus -12.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SRTA+8.57%STLN-4.15%
+133%+51%-31%
Nov 21, 20251 yearNov 20, 2026
SRTA-52.80%STLN-61.09%
+42%-31%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SRTA versus STLN key metrics
MetricSRTASTLN
Share price$4.56$3.00
Market cap$407.30M$305.97M
1-day change-5.59%-5.66%
YTD return-5.20%-15.73%
1-year return+8.57%-4.15%
5-year return-46.79%-55.29%
EPS (TTM)$-0.24$-0.28
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$197.14M$502.73M
Revenue growth (YoY)+34.28%+27.79%
Net income (latest FY)$41.35M$-60.61M
Gross margin20.86%—
Operating margin-11.34%-7.18%
Net margin20.97%-12.06%
52-week high$6.50$7.13
52-week low$3.95$2.32
Distance from 52-week high-29.85%-57.92%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+111.18%+208.33%
Average volume982.75K2.55M
Shares outstanding89.32M101.99M
Employees327641
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • SRTA has outperformed STLN by 12.7 percentage points over the past year.
  • Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus -12.1 cents for Starling Oncology.
  • Strata Critical Medical grew revenue faster in its latest fiscal year (+34.28% vs +27.79%).

About Strata Critical Medical

SRTA stock →

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.

Health Care · Medical/Nursing Services · 327 employees

About Starling Oncology

STLN stock →

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.

Health Care · Medical/Nursing Services · 641 employees

SRTA vs STLN FAQ

Which is bigger, Strata Critical Medical or Starling Oncology?

Strata Critical Medical (SRTA) is larger, with a market capitalization of $407.30M compared with $305.97M for Starling Oncology (STLN).

Which stock has performed better over the past year, SRTA or STLN?

SRTA returned +8.57% over the past 12 months, compared with -4.15% for STLN (price return, excluding dividends). Past performance does not predict future results.

Are Strata Critical Medical and Starling Oncology in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons